The African country of South Sudan has started vaccinating front-line response staff with the Ebola Zaire vaccine candidate v920.
The vaccine’s producer, Merck, has given 2,160 doses of the vaccine candidate V920 (rVSV-ZEBOV) as part of preparedness measures to fight the spread of the Ebola disease, said the World Health Organization (WHO) in a press release on January 28, 2019.
This preventive effort is in reaction to South Sudan’s neighboring country the Democratic Republic of the Congo (DRC), which is now experiencing its 10th Ebola outbreak.
Read more
Comments are closed.